Clinical and anti-inflammatory effects of ultra-short preseasonal vaccine to Parietaria in asthma
- Autori: Scichilone, N; Scalici, V; Arrigo, R; Bellia, V
- Anno di pubblicazione: 2013
- Tipologia: Articolo in rivista (Articolo in rivista)
- OA Link: http://hdl.handle.net/10447/98964
Abstract
The ultra-short course preseasonal allergy vaccine, containing the adjuvant monophosphoryl lipid A (MPL), is effective in treating allergic symptoms; however, the efficacy in controlling asthmatics symptoms has not been fully demonstrated. We aimed at evaluating whether the ultra-short preseasonal course of immunotherapy contributes to asthma control.